+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Markets for Drug Delivery: Transdermal and Inhalation Drug Delivery Technologies in 2015

  • ID: 3385030
  • Report
  • August 2015
  • Region: Global
  • 106 Pages
  • Life Science Intelligence
1 of 3
The Drug Delivery Market was Valued at $8.2 billion in 2014

FEATURED COMPANIES

  • 3M Health Care
  • CareFusion
  • DJO Global
  • Johnson & Johnson
  • Mylan
  • Philips Healthcare
  • MORE
This report explores the dynamic market for transdermal drug patches, iontophoresis devices, dry powder inhalers, metered dose inhalers, and nebulizers.

The market, which was valued at $8.2 billion in 2014, is being driven by powerful regional and economic forces; key among these are the introduction and adoption of generic products, rising caseloads, the pursuit of new and expanded therapeutic indications, and the state of healthcare development in important national markets.

This report, which provides detailed forecasts for product segments, clinical caseloads, and global regions-analyzes the impacts these factors will have through 2020, examines competitive market shares, and highlights the main forces driving and limiting growth in the global market.

Critical Issues Covered in this Report:
- The competitive landscape for transdermal drug delivery and inhalation devices in the U.S. and international markets
- Revenues for key components and devices
- Key caseloads for transdermal drug applications.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 3M Health Care
  • CareFusion
  • DJO Global
  • Johnson & Johnson
  • Mylan
  • Philips Healthcare
  • MORE
1. Executive Summary
1.1 The United States
1.2 Europe
1.3 Asia-Pacific And The Rest Of The World
1.4 Competitive Analysis

Exhibit 1-1: Global Market Forecast For Transdermal And Inhalation Drug Delivery Technologies By Product Type, 2013-2020
Exhibit 1-2: Global Market Forecast For Transdermal And Inhalation Drug Delivery Technologies By Region, 2013-2020
Exhibit 1-3: U.S. Market Forecast For Transdermal And Inhalation Drug Delivery Technologies By Product Type, 2013-2020
Exhibit 1-4: European Market Forecast For Transdermal And Inhalation Drug Delivery Technologies By Product Type, 2013-2020
Exhibit 1-5: Ap & Row Market Forecast For Transdermal And Inhalation Drug Delivery Technologies By Product Type, 2013-2020
Exhibit 1-6: Global Supplier Shares In 2013 And 2014

2. Transdermal And Inhalation Technologies
2.1 Transdermal Technologies
2.1.1 Iontophoresis
2.1.2 Patches
2.1.3 Microneedles
2.2 Inhalation Devices
2.2.1 Dry Powder Inhalers
2.2.2 Metered Dose Inhalers
2.2.3 Nebulizers
2.2.4 Products And Suppliers

Exhibit 2-1: Overview Of Transdermal And Inhalation Drug Delivery Technologies
Exhibit 2-2: Transdermal Technologies By Type
Exhibit 2-3: Transdermal Drug Delivery Technologies: Selected Products And Suppliers In 2015
Exhibit 2-4: Inhalation Technologies By Type
Exhibit 2-5: Inhalation Devices: Selected Products And Suppliers In 2015

3. Transdermal And Inhalation Drug Delivery Technologies: Global Market Analysis
3.1 Patient Volumes And Market Forecasts: Transdermal Drug Delivery Technologies By Region
3.1.1 The United States
3.1.1.1 Cardiovascular
3.1.1.2 Hormone Replacement
3.1.1.3 Neurological/Psychiatric
3.1.1.4 Pain Management
3.1.1.5 Pregnancy Prevention
3.1.1.6 Smoking Cessation
3.1.1.7 Urology
3.1.1.8 Iontophoresis
3.1.1.9 Supplier Shares
3.1.2 Europe
3.1.3 Asia-Pacific And The Rest Of The World
3.2 Patient Volumes And Market Forecasts: Inhalation Drug Delivery Technologies By Region
3.2.1 The United States
3.2.1.1 Competitive Analysis
3.2.2 Europe
3.2.3 Asia-Pacific And The Rest-Of-The-World
3.2.4 Competitive Analysis

Exhibit 3-1: Global Market Forecast For Transdermal And Inhalation Drug Delivery Technologies By Region, 2013-2020
Exhibit 3-2: Global Market Forecast For Transdermal And Inhalation Drug Delivery Technologies By Product Type, 2013-2020
Exhibit 3-3: U.S. Market Forecast For Transdermal Drug Delivery Technologies: Iontophoresis And Transdermal Patches, 2013-2020
Exhibit 3-4: Key Caseloads For Transdermal Patches In The U.S., 2013-2020
Exhibit 3-5: U.S. Market Forecast For Transdermal Patches By Category, 2013-2020
Exhibit 3-6: U.S. Market Forecast For Transdermal Patches By Application, 2013-2020
Exhibit 3-7: U.S. Market Forecast For Iontophoresis Devices, 2013-2020
Exhibit 3-8: U.S. Supplier Shares, Transdermal Drug Delivery Technologies, 2013 And 2014
Exhibit 3-9: European Market Forecast For Transdermal Drug Delivery Technologies: Iontophoresis And Transdermal Patches, 2013-2020
Exhibit 3-10: Key Caseloads For Transdermal Patches In Europe, 2013-2020
Exhibit 3-11: European Market Forecast For Transdermal Patches By Category, 2013-2020
Exhibit 3-12: European Market Forecast For Transdermal Patches By Application, 2013-2020
Exhibit 3-13: European Market Forecast For Iontophoresis Devices, 2013-2020
Exhibit 3-14: Ap & Row Market Forecast For Transdermal Drug Delivery Technologies: Iontophoresis And Transdermal Patches, 2013-2020
Exhibit 3-15: Key Caseloads For Transdermal Patches In Ap & Row Countries, 2013-2020
Exhibit 3-16: Ap & Row Market Forecast For Transdermal Patches By Category, 2013-2020
Exhibit 3-17: Ap & Row Market Forecast For Transdermal Patches By Application, 2013-2020
Exhibit 3-18: Ap & Row Market Forecast For Iontophoresis Devices, 2013-2020
Exhibit 3-19: Ous Supplier Shares, Transdermal Drug Delivery Technologies, 2013 And 2014
Exhibit 3-20: U.S. Market Forecast For Inhalation Technologies By Type, 2013-2020
Exhibit 3-21: U.S. Market Forecast For Dry Powder Inhalers, 2013-2020
Exhibit 3-22: U.S. Market Forecast For Metered Dose Inhalers, 2013-2020
Exhibit 3-23: U.S. Market Forecast For Nebulizers, 2013-2020
Exhibit 3-24: U.S. Supplier Shares, Inhalation Technologies, 2013 And 2014
Exhibit 3-25: European Market Forecast For Inhalation Technologies By Type, 2013-2020
Exhibit 3-26: European Market Forecast For Dry Powder Inhalers, 2013-2020
Exhibit 3-27: European Market Forecast For Metered Dose Inhalers, 2013-2020
Exhibit 3-28: European Market Forecast For Nebulizers, 2013-2020
Exhibit 3-29: Ap & Row Market Forecast For Inhalation Technologies By Type, 2013-2020
Exhibit 3-30: Ap & Row Market Forecast For Dry Powder Inhalers, 2013-2020
Exhibit 3-31: Ap & Row Market Forecast For Metered Dose Inhalers, 2013-2020
Exhibit 3-32: Ap & Row Market Forecast For Nebulizers, 2013-2020
Exhibit 3-33: Ous Supplier Shares, Inhalation Technologies, 2013 And 2014
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
- 3M Health Care
- Actavis (Allergan)
- CareFusion
- DJO Global
- DeVilbiss Healthcare
- GlaxoSmithKline
- Johnson & Johnson
- Monaghan Medical
- Mylan
- Novartis
- Noven Pharmaceuticals (Hisamitsu Pharmaceutical)
- Philips Healthcare
- Salter Labs
- Smiths Medical
- Somerset Pharmaceuticals
- Teikoku Pharma
- Teleflex Medical
- UCB
Note: Product cover images may vary from those shown
Adroll
adroll